NO963029D0 - Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod - Google Patents

Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Info

Publication number
NO963029D0
NO963029D0 NO963029A NO963029A NO963029D0 NO 963029 D0 NO963029 D0 NO 963029D0 NO 963029 A NO963029 A NO 963029A NO 963029 A NO963029 A NO 963029A NO 963029 D0 NO963029 D0 NO 963029D0
Authority
NO
Norway
Prior art keywords
stimulate
blood cells
peripheral blood
core peripheral
cytological activity
Prior art date
Application number
NO963029A
Other languages
English (en)
Other versions
NO963029L (no
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO963029D0 publication Critical patent/NO963029D0/no
Publication of NO963029L publication Critical patent/NO963029L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
NO963029A 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod NO963029L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (zh) 1994-01-20 1994-01-20 用白介素-10激活外周血单核细胞的细胞溶解活性
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
NO963029D0 true NO963029D0 (no) 1996-07-19
NO963029L NO963029L (no) 1996-09-19

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963029A NO963029L (no) 1994-01-20 1996-07-19 Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod

Country Status (10)

Country Link
EP (1) EP0740552A1 (no)
JP (1) JPH09508116A (no)
CN (1) CN1142186A (no)
AU (1) AU707019B2 (no)
FI (1) FI962813A (no)
NO (1) NO963029L (no)
NZ (1) NZ259584A (no)
PL (1) PL175343B1 (no)
SK (1) SK91696A3 (no)
WO (1) WO1995019780A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356010A1 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
RU2322452C2 (ru) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Иммуномодулирующая композиция
US20080081031A1 (en) 2006-09-28 2008-04-03 Schering Corporation Use of Pegylated IL-10 to Treat Cancer
CA2692282A1 (en) * 2007-06-27 2008-12-31 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
DK2379115T3 (da) 2008-12-17 2018-01-29 Merck Sharp & Dohme Fremstilling og anvendelse af mono- og di-PEG-IL-10
BR112015026122A8 (pt) 2013-04-18 2020-01-21 Armo Biosciences Inc agente de polietileno glicol-il-10 (peg-il-10), seu uso, composição farmacêutica, contentor estéril e kit
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
US10010588B2 (en) 2013-08-30 2018-07-03 Armo Biosciences, Inc. Methods of using pegylated interleukin-10 for treating hyperlipidemia
US11413332B2 (en) 2013-11-11 2022-08-16 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10293043B2 (en) 2014-06-02 2019-05-21 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
WO2016064817A1 (en) 2014-10-22 2016-04-28 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
AU2016268403A1 (en) 2015-05-28 2017-12-07 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
EP3341012A4 (en) 2015-08-25 2019-03-20 Armo Biosciences, Inc. METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
WO2023072850A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE68836B1 (en) * 1991-01-16 1996-07-10 Schering Corp Use of interleukin-10 in adoptive immunotherapy of cancer
CZ282523B6 (cs) * 1991-01-16 1997-07-16 Schering Corporation Iterleukin - 10 pro léčení nádorů, farmaceutický prostředek jej obsahující, jeho použití a způsob výroby
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
FI962813A0 (fi) 1996-07-11
FI962813A (fi) 1996-07-11
AU5842594A (en) 1995-08-08
NZ259584A (en) 1998-01-26
EP0740552A1 (en) 1996-11-06
AU707019B2 (en) 1999-07-01
SK91696A3 (en) 1997-04-09
PL175343B1 (pl) 1998-12-31
PL315513A1 (en) 1996-11-12
JPH09508116A (ja) 1997-08-19
CN1142186A (zh) 1997-02-05
WO1995019780A1 (en) 1995-07-27
NO963029L (no) 1996-09-19

Similar Documents

Publication Publication Date Title
NO963029D0 (no) Anvendelse av IL-10 for å stimulere cytologisk aktivitet av enkjernete celler i perifert blod
AU643646B2 (en) Low energy consumptive device for aquisition of data relating to abnormal heart muscle activity
IT8647603A0 (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
HK1005985A1 (en) Combined use of hyaluronic acid and therapeutic agents to improve the therapeutic effect
PL330862A1 (en) Clinical application of proteinous kinase c in order to increase clinical effectiveness of anticarcinogenic pharmaco- and radiotherapy
ITMI950575A0 (it) Preparati igienici e cosmetici per prevenire e trattare malattie della pelle nonche' procedimento per il loro ottenimento
NZ221090A (en) Retinoid composition for treatment of sun damaged skin
TR23668A (tr) Insan gövdesi akintisinin toplanmasi
GB8606913D0 (en) Treatment of sickle cell disease
AU5479998A (en) Use of biosensors to diagnose plant diseases
DE3786714D1 (de) Therapeutisches mittel fuer hautgeschwuere.
ZA898605B (en) Compositions for topical treatment of skin diseases
IT1074824B (it) Metodo di preparazione di "clusters" metallo-carbonilici immobilizzati in zeoliti e loro impiego come catalizzatori eterogenei
PL316433A1 (en) Analogues of human alpha-1-antichimotropsin exhibiting inhibitory activity in respect to elastase
AU4306197A (en) Use of inhibitors of the activity of retinoic acid to promote healing
GB8723826D0 (en) Topical application for skin care
IT8220954A0 (it) Composti attivi nel trattamento dell'ulcera e di sintomi allergici della pelle
GB9216506D0 (en) Improvements in or relating to the treatment of sickle cell disease
ZA94212B (en) Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
AU7903898A (en) Assessment of human skin damage following exposure to harmful agents
AU3708295A (en) Use of receptor agonists to stimulate superoxide dismutase activity
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
EP0444931A3 (en) Use of 3-oxygermylpropionic acid to treat and prevent diabetes-dependent autoimmune diseases
IL122359A0 (en) Stable gel formulation for topical treatment of skin conditions
NO922413L (no) Utstyr for bruk i diagnostisering av sykdommer